Expression of the insulin-like growth factor I receptor C terminus as a myristylated protein leads to induction of apoptosis in tumor cells

Cancer Research

Volumn 58, Issue 3, 1998, Pages 570-576

  Liu, Yimao ^a   Lehar, Sophie ^a   Corvi, Christopher ^a   Payne, Gillian ^a   O'Connor, Rosemary ^a,b  

^a Apoptosis Technology Inc   (United States)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE; RECEPTOR PROTEIN; SOMATOMEDIN C RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CYTOTOXICITY; EXPRESSION VECTOR; GLIOBLASTOMA; HUMAN; HUMAN CELL; MYRISTYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RAT; TUMOR CELL LINE;

ACYLATION; ADENOCARCINOMA; ANIMALS; APOPTOSIS; BRAIN NEOPLASMS; BREAST NEOPLASMS; FEMALE; GLIOBLASTOMA; HUMANS; MICE; MUTAGENESIS, SITE-DIRECTED; NEOPLASM PROTEINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, IGF TYPE 1; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY; ULTRAVIOLET RAYS;

EID: 0032006082     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Baserga, R., Sell, C., Porcu, P., and Rubini, M. The role of the IGF-1 receptor in the growth and transformation of mammalian cells. Cell Prolif., 27: 63-71, 1994.
2. Sell, C., Dumenzil, G., Deveaud, C., Miura, M., Coppola, D., DeAngelis, T., Rubin, R., Efstratiadis, A., and Baserga, R. Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts. Mol. Cell. Biol., 14: 3604-3612, 1994.
3. Barres, B. A., Schmid, R., Sendter, M., and Raff, M. C. Multiple extracellular signals are required for long-term oligodendrocyte survival. Development (Camb.), 118: 283-295, 1993.
4. Harrington, E., Bennett, M. R., Fanidi, A., and Evan, G. I. c-Myc induced apoptosis is inhibited by specific cytokines. EMBO J., 13: 3286-3295, 1994.
5. Neff, N. T., Prevette, D., Houenou, L. J., Lewis, M. E., Glicksman, M. A., Yin, Q. W., and Oppenheim, R. W. Insulin-like growth factors: putative muscle-derived trophic agents that promote motoneuron survival. J. Neurobiol., 24: 1578-1588, 1993.
6. Jung, Y-K., Miura, M., and Yuan, J. Suppression of interleukin-1B-converting enzyme-mediated cell death by insulin-like growth factor. J. Biol. Chem., 271: 5112-5117, 1996.
7. Rodriguez-Tarduchy, G., Collins, M. K. L., Garcia, I., and Lopez-Rivas, A. Insulin-like growth factor-1 inhibits apoptosis in IL-3-dependent hemopoietic cells. J. Immunol., 149: 535-540, 1992.
8. O'Connor, R., Kauffmann-Zeh, A., Liu, Y., Lehar, S., Evan, G. I., Baserga, R., and Blättler, W. A. Identification of domains of the IGF-IR that are required for protection from apoptosis. Mol. Cell. Biol., 17: 427-435, 1997.
9. Alessi, D. R., Andjelkovic, M., Caudwell, B., Cron, P., Morrice, N., Cohen, P., and Hemmings, B. A. Mechanism of activation of protein kinase B by insulin and IGF-I. EMBO J., 15: 6541-6550, 1996.
10. Kauffmann-Zeh, A., Rodriguez-Viciana, P., Ulrich, E., Gilbert, C., Coffer, P., Downward, J., and Evan, G. Suppression of c-myc-induced apoptosis by ras signaling through PI(3)K and PKB. Nature (Lond.), 385: 544-548, 1997.
11. Dudek, H., Datta, S. R., Franke, T. F., Birnbaum, M. J., Yao, R., Cooper, G. M., Segal, R. A., Kaplan, D. R., and Greenberg, M. E. Regulation of neuronal survival by the serine threonine kinase AKT. Science (Washington DC), 275: 661-664, 1997.
12. Kulik, G., Klippel, A., and Weber, M. J. Anti-apoptotic signaling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase and Akt. Mol. Cell. Biol., 17: 1595-1605, 1997.
13. Christofori, G., Naik, P., and Hanahan, D. A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature (Lond.), 369: 414-418, 1994.
14. Naik, P., Karrim, J., and Hanahan, D. The rise and fall of apoptosis during multistage tumorigenesis: down modulation contributes to tumor progression from angiogenic progenitors. Genes Dev., 10: 2105-2116, 1996.
15. LeRoith, D., Werner, H., Beitner-Johnson, D., and Roberts, C. T. Molecular and cellular aspects of the insulin-like growth factor-I receptor. Endocr. Rev., 16: 143-163, 1995.
16. Werner, H., and LeRoith, D. The role of the insulin-like growth factor system in human cancer. Adv. Cancer Res., 168: 183-223, 1996.
17. Baserga, R. The insulin-like growth factor receptor: a key to tumor growth? Cancer Res., 55: 249-252, 1995.
18. Pollak, M. N., Perdue, J. F., Margolese, R. G., Raer, K., and Richard, M. Presence of somatomedin receptors on primary human breast and colon carcinomas. Cancer Lett., 38: 223-230, 1987.
19. Yee, D., Paik, S., Lebovic, G. S., Marcus, R. R., Favoni, R. E., Cullen, K. J., Lippman, M. E., and Rosen, N. Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer. Mol. Endocrinol., 3: 509-514, 1989.
20. Resnicoff, M., Abraham, D., Yutanawiboonchai, W., Rotman, H., Kajstura, J., Rubin, R., Zoltick, P., and Baserga, R. The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res., 55: 2463-2469, 1995.
21. Resnicoff, M., Burgaud, J., Rotman, H. L., Abraham, D., and Baserga, R. Correlation between apoptosis, tumorigenesis, and levels of insulin-like growth factor I receptors. Cancer Res., 55: 3739-3741, 1995.
22. Hongo, A., D'Ambrosio, C., Miura, M., Morrione, A., and Baserga, R. Mutational analysis of the mitogenic and transforming activities of the insulin-like growth factor I receptor. Oncogene, 12: 1231-1238, 1996.
23. Resh, M. D. Myristylation and palmitylation of Src family members: the fats of the matter Cell, 76: 411-413, 1994.
24. Miura, M., Zhu, H., Rotello, R., Hartwieg, E. A. and Yuan, J. Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homologue of the C. elegans death gene ced-3. Cell, 75: 653-670, 1993.
25. Kumar, S., Kinoshita, M., Noda, M., Copeland, N. G., and Jenkins, N. A. Induction of apoptosis by the mouse Nedd2 gene, which encodes a protein similar to the product of the Caenorhabididtis elegans cell death gene Ced-3 and the mammalian IL-1β-converting enzyme. Genes Dev., 8: 1613-1626, 1994.
26. Chittenden, T., Flemington, C., Houghton, A. B., Ebb, R. G., Gallo, G. J., Elangovan, B., Chinnadurai, G., and Lutz, R. J. A conserved domain in Bak, distinct from BHI and BH2, mediates cell death and protein binding functions. EMBO J., 14: 5589-5596, 1996.
27. Li, S., Resnicoff, M., and Baserga, R. Effect of mutations at serines 280-1283 on the mitogenic and transforming activities of the insulin-like growth factor receptor. J. Biol. Chem., 271: 12254-12260, 1996.
28. Heldin, C-H. Dimerization of cell surface receptors in signal transduction. Cell, 80: 213-223, 1995.
29. Cohen, G. B., Ren, R., and Baltimore, D. Modular binding domains in signal transduction. Cell, 80: 237-248, 1995.
30. Klippel, A., Reinhard, C., Kavanaugh, W. M., Apel, G., Escobedo, M. A., and Williams, L. T. Membrane localization of phosphatidylinositol 3-kinase is sufficient to activate multiple signal-transducing kinase pathways. Mol. Cell. Biol., 16: 4117-4127, 1996.
31. Hemmings, B. A. Akt signaling; linking membrane events to life and death decisions. Science (Washington DC), 275: 628-630, 1997.
32. O'Neil, T. J., Craparo, A., and Gustafson, T. A. Characterization of an interaction between insulin receptor substrate I and the insulin receptor by using the two-hybrid system. Mol. Cell. Biol., 14: 6433-6442, 1994.
33. Tartaere-Deckert, S., Sawka-Verhelle, D., Murdaca, J., and Van Obberghen, E. Evidence for a differential interaction of SHC and the insulin receptor substrate I (IRS-1) with the insulin-like growth factor-1 receptor in the yeast two hybrid system. J. Biol. Chem., 270: 23456-23460, 1995.
34. Yamamoto, K., Altschuler, D., Wood, E., Horlick, K., Jacobs, S., and Lapetino, E. G. Association of phosphorylated insulin-like growth factor I receptor with the SH2 domains of phosphatidylinositol 3-kinase p85. J. Biol. Chem., 267: 11337-11343, 1992.
35. Boldin, M. P., Varfolomeev, E. E., Pancer, Z., Mett, I. L., Camonis, J. H., and Wallach, D. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J. Biol. Chem., 270: 7795-7798, 1995.
36. Chinnaiyan, A. M., O'Rourke, K., Tewari, M., and Dixit, V. M. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell, 81: 505-512, 1995.
37. Ullrich, A., Gray, A. W., Yang-Feng, M., Tsubokawa, C., Collins, W., Henzel, T., LeBon, S., Katchuria, S., Chen, E., Jakobs, S., Francke, Y., Ramachandran, J., and Fujita-Yamaguchi, Y. Insulin-like growth factor-I receptor primary structure; comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J., 5: 2503-2512, 1986.